| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Voyager Therapeutics, Inc. (VYGR) has 15 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. VYGR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 484.1K | $2.01M | - | |
| COO | 199.7K | $828.9K | - | |
| Other | 183.9K | $763.2K | - | |
| CFO | 151.4K | $628.4K | - | |
| Other | 145.7K | $604.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 2, 2025 | Sandrock Alfred67 | President And CEO | Sell | 10,885 | $3.43 | $37,335.55 | -2.5% | -8.5% | +16.1% | |
| Feb 20, 2025 | Sandrock Alfred67 | President And CEO | Sell | 11,702 | $4.24 | $49,616.48 | -3.8% | -26.1% | -18.1% | |
| Feb 20, 2025 | Swartz Robin69 | COO &Cbo | Sell | 3,894 | $4.25 | $16,549.50 | -3.8% | -26.1% | -18.1% | |
| Feb 20, 2025 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 3,305 | $4.26 | $14,079.30 | -4.1% | -26.1% | -18.1% | |
| Feb 11, 2025 | Sandrock Alfred67 | President &CEO | Sell | 16,644 | $4.45 | $74,065.80 | -5.1% | -20.3% | -13.2% | |
| Feb 11, 2025 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 5,413 | $4.45 | $24,087.85 | -6.3% | -20.3% | -13.2% | |
| Feb 11, 2025 | Swartz Robin69 | COO &Cbo | Sell | 6,950 | $4.45 | $30,927.50 | -6.4% | -20.3% | -13.2% | |
| Feb 11, 2025 | Fahey Sandell Jacquelyn | Chief Legal Officer | Sell | 4,358 | $4.45 | $19,393.10 | -5.1% | -20.3% | -13.2% | |
| Jan 14, 2025 | Swartz Robin69 | COO &Cbo | Sell | 3,087 | $5.09 | $15,712.83 | -2.7% | -36.8% | -18.2% | |
| Jan 14, 2025 | Carter Todd Alfred69 | Chief Scientific Officer | Sell | 1,191 | $5.13 | $6,109.83 | -1.4% | -36.8% | -18.2% |